RODRIGUEZ ARRIETA, L. A. et al. When skin reactions interrupt bone therapy: severe cutaneous adverse reaction to romosozumab leading to treatment discontinuation. European Journal of Case Reports in Internal Medicine, v. 12, n. 9, 25 Aug.2025.